Malignancies

17 clinical trials · Condition

Record	Firm	Date
A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies (NCT05253105)	Shanghai Junshi Bioscience Co., Ltd.	2022-03-15
9-ING-41 in Patients With Advanced Cancers (NCT03678883)	Actuate Therapeutics Inc.	2019-01-04
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies (NCT03236857)	AbbVie	2017-11-08
Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers (NCT03005782)	Regeneron Pharmaceuticals	2016-11-07
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. (NCT03384511)	Shandong Cancer Hospital and Institute	2016-09-30
Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143 (NCT02521389)	MEI Pharma, Inc.	2015-06-29
Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy (NCT01404728)	University of Colorado, Denver	2013-01-08
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies (NCT01407380)	Pathway Therapeutics, Inc.	2011-06-01
Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies (NCT00329329)	Agennix	2006-05-01
Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma (NCT00316511)	Agenus Inc.	2006-03-01
Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) (NCT00320827)	Daiichi Sankyo

Track Malignancies automatically

Every clearance here is in the API, with alerts when new ones post.